Artificial Intelligence, Machine Learning, and Data Science's positive impact on the Pharma Industry and patients are astounding.
In this episode, Tommaso Mansi, Vice President, AI/ML and Digital Health, R&D, The Janssen Pharmaceutical Companies of Johnson & Johnson talks about the development of AI approaches to the development of medications and treatments for specific diseases with the help of digitized biomedical data. Tommaso shares the importance of having proper data governance in the research lab and why humans will always be necessary to produce breakthroughs in partnership with AI.
Tune in and learn more about AI's role in data in R&D!
Click this link to the show notes, transcript, and resources: outcomesrocket.health
Outcomes Rocket